市場調查報告書
商品編碼
1521163
顱內支架市場報告按類型(自擴張支架、球囊擴張支架、支架輔助線圈栓塞)、應用(顱內狹窄、腦動脈瘤)、最終用戶(醫院、門診手術中心)和地區2024-2032Intracranial Stents Market Report by Type (Self-Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization), Application (Intracranial Stenosis, Brain Aneurysm), End User (Hospitals, Ambulatory Surgery Centers), and Region 2024-2032 |
IMARC Group年,全球顱內支架市場規模達到4.275億美元。各種腦血管疾病的盛行率不斷上升,老年人口迅速成長,以及患者和醫療保健提供者對非侵入性和微創手術的偏好轉變,是推動市場的一些關鍵因素。
顱內支架是指由鎳鈦諾或不銹鋼等生物相容性材料製成的小型管狀醫療器械,專門設計用於以侵入性較小的方式治療各種腦血管疾病。它們的特點是提高了與多種成像技術的兼容性,允許在血管中精確導航,因此可以部署在目標部位,並具有各種尺寸和配置,以適應個體的解剖特徵。它們最常安裝在大腦中狹窄或薄弱的血管內,以提供結構支撐並恢復血流。透過保持血管通暢,它們可以增強大腦的血流量,有助於降低中風和與血管受限或受損相關的其他併發症的風險。顱內支架廣泛應用於血管成形術或血管內彈簧圈等手術和程序中,以治療包括顱內動脈瘤或狹窄在內的各種病症。顱內支架的一些優點包括對血管的長期支持、更短的恢復時間和減少住院時間。
全球市場主要受到腦動脈瘤和中風等各種腦血管疾病盛行率上升的推動。這可以歸因於老年人口的快速成長,他們更容易患上這些疾病。與此一致的是,顱內支架生產技術的不斷進步,帶來了具有更高靈活性、可導航性和徑向強度的創新和先進產品,正在推動市場發展。此外,對神經系統疾病的早期診斷和治療的日益重視正在推動對有效治療解決方案的需求,這反過來又導致顱內支架的使用率更高。此外,患者和醫療保健提供者對恢復時間較短的非侵入性和微創手術的偏好的轉變也是市場成長的重要誘導因素。除此之外,一些國家的政府機構和私人保險公司對顱內支架手術的優惠報銷政策正在創造積極的市場前景。主要參與者之間為擴大市場佔有率而進行的各種策略合作、併購 (M&A) 和合作夥伴關係進一步推動了市場的發展。除此之外,磁振造影(MRI)、電腦斷層掃描(CT)和血管攝影等醫學影像技術的眾多創新正在對市場產生積極影響。促進市場發展的其他一些因素包括快速城市化、醫療保健支出增加、醫院基礎設施升級(特別是在發展中國家)以及廣泛的研發(R&D)活動。
The global intracranial stents market size reached US$ 427.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,099.9 Million by 2032, exhibiting a growth rate (CAGR) of 10.74% during 2024-2032. The rising prevalence of various cerebrovascular disorders, rapidly growing geriatric population, and shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures represent some of the key factors driving the market.
Intracranial stents refer to small, tubular medical devices that are made from biocompatible materials such as nitinol or stainless steel, specifically designed for treating various cerebrovascular conditions in a less invasive way. They are characterized by improved compatibility with multiple imaging techniques, allowing precise navigation through blood vessels and are therefore deployed at the target site, with various sizes and configurations available to accommodate individual anatomical features. They are most commonly installed within narrowed or weakened blood vessels in the brain to provide structural support and restore blood flow. By maintaining vessel patency, they provide enhanced blood flow to the brain which helps in reducing the risk of stroke and other complications associated with restricted or damaged blood vessels. Intracranial stents find extensive applications in surgeries and procedures such as angioplasty or endovascular coiling, to treat various conditions including intracranial aneurysms or stenosis. Some of the advantages provided by intracranial stents include long-term support to blood vessels, shorter recovery times, and reduced hospital stays.
The global market is primarily driven by the rising prevalence of various cerebrovascular disorders such as cerebral aneurysms and strokes. This can be attributed to the rapidly growing geriatric population that is more susceptible to developing these ailments. In line with this, continual technological advancements in intracranial stent production resulting in innovative and advanced products with improved flexibility, navigability, and radial strength are fueling the market. Moreover, an enhanced emphasis on early diagnosis and treatment of neurological conditions is propelling the demand for effective treatment solutions, which in turn is resulting in a higher uptake of intracranial stents. Also, the shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures with shorter recovery times is acting as a significant growth-inducing factor for the market. In addition to this, favorable reimbursement policies for intracranial stent procedures by government agencies and private insurance providers in several countries is creating a positive market outlook. The market is further fueled by various strategic collaborations, merger and acquisitions (M&As) and partnerships among key players to expand their market presence. Apart from this, numerous innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and angiography are impacting the market positively. Some of the other factors contributing to the market include rapid urbanization, rising healthcare expenditure, upgradation of hospital infrastructure, particularly in developing countries and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each segment of the global intracranial stents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.
Self-Expanding Stents
Balloon Expanding Stents
Stent-Assisted Coil Embolization
The report has provided a detailed breakup and analysis of the intracranial stents market based on the type.This includes self-expanding stents, balloon expanding stents, and stent-assisted coil embolization. According to the report, self-expanding stents represented the largest segment.
Intracranial Stenosis
Brain Aneurysm
The report has provided a detailed breakup and analysis of the intracranial stents market based on the application. This includes intracranial stenosis and brain aneurysm. According to the report, intracranial stenosis represented the largest segment.
Hospitals
Ambulatory Surgery Centers
A detailed breakup and analysis of the intracranial stents market based on the end user has also been provided in the report. This includes hospitals and ambulatory surgery centers. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intracranial stents. Some of the factors driving the North America intracranial stents market included growing geriatric population, continual technological advancements, shifting preference towards non-invasive and minimally invasive procedures, high healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global intracranial stents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Acandis GmbH, Balt Group, Medtronic Public Limited Company, MicroPort Scientific Corporation, Phenox GmbH, Stryker Corporation, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.